![](/img/cover-not-exists.png)
Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer
Suresh S. Ramalingam, R. Donald Harvey, Nabil Saba, Taofeek K. Owonikoko, John Kauh, Dong M. Shin, Shi-Yong Sun, Sandra Strychor, Mourad Tighiouart, Merrill J. Egorin, Haian Fu, Fadlo R. KhuriVolume:
116
Year:
2010
Language:
english
Pages:
7
DOI:
10.1002/cncr.25264
File:
PDF, 151 KB
english, 2010